Showing results (1151-1160 of 2,445) with videos related to
Sort By:
Pageof 245
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2024
Associations Among Optimal Lung Cancer Treatment, Clinical Outcomes, and Health Care Utilization in Patients Who Underwent Comprehensive Genomic ProfilingAdam C Powell, Elifnur Yay Donderici, Nicole J Zhang, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 20, 2023
Development and Validation of a Nomogram for Predicting Postoperative Early Relapse and Survival in Hepatocellular CarcinomaYongzhu He, Laihui Luo, Renfeng Shan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 5, 2024
Molecular Targets and Therapies for Ampullary CancerMonica Arun Patel, Jeremy D Kratz, Alexander S Carlson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2023
Patient Navigation for Timely, Guideline-Adherent Adjuvant Therapy for Head and Neck Cancer: A National Landscape AnalysisEvan M Graboyes, Michelle Chappell, Kelsey A Duckett, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 18, 2026
Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) TestJulia R Trosman, Christine B Weldon, Allison W Kurian, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2026
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In OncologySusan M Swetter, Douglas Johnson, Mark R Albertini, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 7, 2026
Genetics-Supported Mainstream Testing Improves Access and Efficiency for Patients With Breast CancerKristen M Shannon, Mackenzie Wooters, Geoffrey G Fell, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, et al.Journal of the National Comprehensive Cancer Network : JNCCN|July 9, 2026
What is Optimal Neoadjuvant Therapy in HER2-Positive Breast Cancer?Daniel S Peiffer, Caitlin Maloney, Nan ChenJournal of the National Comprehensive Cancer Network : JNCCN|August 17, 2026
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In OncologyJames Stevenson, Gregory J Riely, Douglas E Wood, et al.Pageof 245